RxDoctor Payments Data

Andrea Galehouse

Physician Assistant · Medina, OHNPI 1083738710

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,803 of the $14,283 with a category attached, or 75.6%. 43 manufacturers reported payments, led by Corcept Therapeutics at 25.5% of the total. 2025 is the largest year on record at $5,025, 2.1 times the $2,362 reported in 2021. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,283in general payments, 2019–2025

Across 601 payments — averaging $23.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$4K
  • AstraZeneca$2K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Novo Nordisk$980
  • Astellas Pharma US Inc$659
  • plus $4K from 37 others

What the payments were for

  • Speaking & faculty fees$2,09015%
  • Travel & lodging$1,0217%
  • Food & beverage$10,80376%
  • Education$3703%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,283 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide74$89,956
FarxigaDapagliflozin Propanediol49$46,921
TrulicityDulaglutide38$45,930
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$38,285
JardianceEmpagliflozin19$17,502
Trijardy XrEmpaglifloz/Linaglip/Metformin16$15,115
MounjaroTirzepatide13$12,708
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,610
Rosuvastatin Calcium193$1,487
Desvenlafaxine Succinate ErDesvenlafaxine Succinate22$1,484
Albuterol Sulfate HfaAlbuterol Sulfate63$1,456
Gabapentin57$1,320
Levothyroxine Sodium135$1,302
Losartan Potassium143$1,239
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$980$89,95674 claims
Lilly USA, LLCTrulicity, Mounjaro$1,091$58,63751 claims
AstraZenecaFarxiga$1,852$46,92149 claims
GSKTrelegy Ellipta$190$38,28536 claims
Boehringer IngelheimJardiance, Trijardy Xr$215$32,61635 claims
AbbVieSynthroid$1,606$21416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Medina

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →